Headlines

Lonza strengthens ADC offering with Synaffix acquisition

Lonza has acquired Synaffix B.V., a biotech company focused on commercializing its clinical-stage technology platform for the development of antibody drug conjugates (ADCs).

invoX Pharma increases investment in pHion Therapeutics to develop mRNA vaccines

invoX Pharma has completed a second tranche of investment of pHion Therapeutics, a next-generation mRNA vaccine company.

Avacta acquires rapid diagnostic test firm Coris Bioconcept

Avacta Group has acquired Coris Bioconcept, a European manufacturer of rapid diagnostic test kits.

Global obesity drugs sales could top $44bn in 2030, says Bloomberg Intelligence

Sales of branded anti-obesity drugs (AOB) could hit $44 billion in 2030 vs. $2.5 billion in 2022, with just under 70% stemming from the US, according to a report from Bloomberg Intelligence.